StonvexLoading…
StonvexStonvexStonvexCore line items from MDAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.65M | $29.58M | $18.06M | $25.37M |
Operating Income | $-8.60M | $-6.58M | $-12.98M | $-2.65M |
Net Income | $-7.57M | $-15.16M | $-20.85M | $-2.91M |
EPS (Diluted) | $-0.29 | $-0.85 | $-1.48 | $-0.22 |
Total Assets | $21.41M | $12.10M | $10.69M | $18.72M |
Total Liabilities | $27.13M | $19.35M | $12.40M | $6.72M |
Cash & Equivalents | $15.40M | $5.20M | $4.79M | $14.17M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 30.69M | 22.59M | 16.29M | 13.17M |